1022 related articles for article (PubMed ID: 30332562)
1. Pathophysiology of Sickle Cell Disease.
Sundd P; Gladwin MT; Novelli EM
Annu Rev Pathol; 2019 Jan; 14():263-292. PubMed ID: 30332562
[TBL] [Abstract][Full Text] [Related]
2. The Red Blood Cell-Inflammation Vicious Circle in Sickle Cell Disease.
Nader E; Romana M; Connes P
Front Immunol; 2020; 11():454. PubMed ID: 32231672
[TBL] [Abstract][Full Text] [Related]
3. Heme triggers TLR4 signaling leading to endothelial cell activation and vaso-occlusion in murine sickle cell disease.
Belcher JD; Chen C; Nguyen J; Milbauer L; Abdulla F; Alayash AI; Smith A; Nath KA; Hebbel RP; Vercellotti GM
Blood; 2014 Jan; 123(3):377-90. PubMed ID: 24277079
[TBL] [Abstract][Full Text] [Related]
4. Sickle cell disease, vasculopathy, and therapeutics.
Kassim AA; DeBaun MR
Annu Rev Med; 2013; 64():451-66. PubMed ID: 23190149
[TBL] [Abstract][Full Text] [Related]
5. The role of blood rheology in sickle cell disease.
Connes P; Alexy T; Detterich J; Romana M; Hardy-Dessources MD; Ballas SK
Blood Rev; 2016 Mar; 30(2):111-8. PubMed ID: 26341565
[TBL] [Abstract][Full Text] [Related]
6. Newer aspects of the pathophysiology of sickle cell disease vaso-occlusion.
Conran N; Franco-Penteado CF; Costa FF
Hemoglobin; 2009; 33(1):1-16. PubMed ID: 19205968
[TBL] [Abstract][Full Text] [Related]
7. Targeting novel mechanisms of pain in sickle cell disease.
Tran H; Gupta M; Gupta K
Hematology Am Soc Hematol Educ Program; 2017 Dec; 2017(1):546-555. PubMed ID: 29222304
[TBL] [Abstract][Full Text] [Related]
8. Targeting novel mechanisms of pain in sickle cell disease.
Tran H; Gupta M; Gupta K
Blood; 2017 Nov; 130(22):2377-2385. PubMed ID: 29187376
[TBL] [Abstract][Full Text] [Related]
9. Sickle cell disease: current treatment and emerging therapies.
Neumayr LD; Hoppe CC; Brown C
Am J Manag Care; 2019 Nov; 25(18 Suppl):S335-S343. PubMed ID: 31809007
[TBL] [Abstract][Full Text] [Related]
10. Thromboinflammatory mechanisms in sickle cell disease - challenging the hemostatic balance.
Conran N; De Paula EV
Haematologica; 2020 Oct; 105(10):2380-2390. PubMed ID: 33054078
[TBL] [Abstract][Full Text] [Related]
11. MASP-2 and MASP-3 inhibitors block complement activation, inflammation, and microvascular stasis in a murine model of vaso-occlusion in sickle cell disease.
Belcher JD; Nguyen J; Chen C; Abdulla F; Conglin R; Ivy ZK; Cummings J; Dudler T; Vercellotti GM
Transl Res; 2022 Nov; 249():1-12. PubMed ID: 35878790
[TBL] [Abstract][Full Text] [Related]
12. Sickle cell disease vasculopathy: a state of nitric oxide resistance.
Wood KC; Hsu LL; Gladwin MT
Free Radic Biol Med; 2008 Apr; 44(8):1506-28. PubMed ID: 18261470
[TBL] [Abstract][Full Text] [Related]
13. Mechanisms of vasculopathy in sickle cell disease and thalassemia.
Morris CR
Hematology Am Soc Hematol Educ Program; 2008; ():177-85. PubMed ID: 19074078
[TBL] [Abstract][Full Text] [Related]
14. Oxidative stress in sickle cell disease; pathophysiology and potential implications for disease management.
Nur E; Biemond BJ; Otten HM; Brandjes DP; Schnog JJ;
Am J Hematol; 2011 Jun; 86(6):484-9. PubMed ID: 21544855
[TBL] [Abstract][Full Text] [Related]
15. Intravascular hemolysis and the pathophysiology of sickle cell disease.
Kato GJ; Steinberg MH; Gladwin MT
J Clin Invest; 2017 Mar; 127(3):750-760. PubMed ID: 28248201
[TBL] [Abstract][Full Text] [Related]
16. Vascular pathophysiology of sickle cell disease.
Connes P; Renoux C; Joly P; Nader E
Presse Med; 2023 Dec; 52(4):104202. PubMed ID: 37944640
[TBL] [Abstract][Full Text] [Related]
17. Ischemia-Reperfusion Injury in Sickle Cell Disease: From Basics to Therapeutics.
Ansari J; Gavins FNE
Am J Pathol; 2019 Apr; 189(4):706-718. PubMed ID: 30904156
[TBL] [Abstract][Full Text] [Related]
18. Vasculopathy and pulmonary hypertension in sickle cell disease.
Potoka KP; Gladwin MT
Am J Physiol Lung Cell Mol Physiol; 2015 Feb; 308(4):L314-24. PubMed ID: 25398989
[TBL] [Abstract][Full Text] [Related]
19. Novel Sickle Cell Disease Therapies: Targeting Pathways Downstream of Sickling.
Morrone K; Mitchell WB; Manwani D
Semin Hematol; 2018 Apr; 55(2):68-75. PubMed ID: 30616808
[TBL] [Abstract][Full Text] [Related]
20. Role of oxidative stress in the pathogenesis of sickle cell disease.
Chirico EN; Pialoux V
IUBMB Life; 2012 Jan; 64(1):72-80. PubMed ID: 22131167
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
